pharmacodynamic properties

Related by string. * pharmacodynamics . Pharmacodynamic . Pharmacodynamics : safety tolerability pharmacodynamics . pharmacodynamic parameters . pharmacokinetic pharmacodynamic PK PD . pharmacodynamic profile . pharmacokinetic pharmacodynamic / prop erties . PROPERTIES . Properties : Hang Lung Properties . Colonial Properties . Cousins Properties . Properties Trust * *

Related by context. Frequent words. (Click for all words.) 71 pharmacokinetic properties 70 pharmacokinetic profiles 69 administered subcutaneously 69 pharmacodynamic effects 69 APOPTONE 69 tolerability profile 68 orally bioavailable 68 pharmacokinetic profile 67 CCX# 67 SRT# [003] 67 antithrombotic 67 active comparator 67 oral bioavailability 67 Azedra 67 Rebif ® 67 GLPG# 67 SCH # 66 pegylated 66 DAVANAT 66 Carfilzomib 66 Lu AA# 66 tanespimycin 66 tipranavir 66 adecatumumab 66 6R BH4 66 ZD# [001] 66 antitumor activity 66 novel anticancer 66 Sym# 66 PS# [001] 65 PREZISTA r 65 mycophenolate mofetil 65 CA4P 65 Targretin 65 pertuzumab 65 LY# [003] 65 BAY #-# 65 PXD# 65 efficacy 65 radiolabeled 65 glargine 65 nab paclitaxel 65 diabetic neuropathic pain 65 seliciclib 65 pharmacodynamic 65 tolerability 65 biodistribution 65 decitabine 65 BrachySil 65 zileuton 65 Preclinical studies 64 nitazoxanide 64 thymalfasin 64 noninferiority 64 potent antiviral 64 partial agonist 64 calcitonin 64 achieved statistical significance 64 Pharmacokinetic 64 CR# vcMMAE 64 dosing regimens 64 xenograft models 64 genotoxicity 64 rHuPH# 64 tezampanel 64 immunomodulatory 64 intravenously administered 64 talabostat 64 glatiramer acetate 64 antiviral activity 64 fluticasone propionate 64 Serdaxin 64 axitinib 64 #ME# 64 BNC# 64 goserelin 64 #mg dose [001] 64 CYT# 63 elotuzumab 63 cardiac toxicity 63 Amrubicin 63 Excellarate 63 OncoVEX GM CSF 63 CYC# 63 SNRI 63 ANG# 63 eltrombopag 63 enfuvirtide 63 pharmacodynamics 63 OXi# 63 teriparatide 63 Vilazodone 63 Combination therapy 63 nelfinavir 63 INTELENCE 63 proteasome inhibitors 63 NGX# 63 pharmacokinetic studies 63 NexACT 63 temsirolimus 63 dose regimens

Back to home page